Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

Sanara MedTech Inc.NASDAQ: SMTI

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization dips below year-ago levels

Q1 FY2026 depreciation & amortization of $587.25K fell 47.8% year over year, behind the +456.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 97.7% from the prior quarter. Over 3 fiscal years it compounded at +129.2% a year.

Context

  • Depreciation & amortization amounted to 27.7% of revenue in FY2025, up 22.0 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -47.8% toward the trailing-twelve-month pace of +456.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$587.25K-97.7% QoQ
Last fiscal yearDec 2025
$28.56M+480.1% YoY
LTMMar 2026
$28.02M+456.0% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-47.8%——
1 year+480.1%——
3-year CAGR+129.2%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
28.56M USD
Year-over-year change
+480.1%
4-year CAGR
+163.0%

Depreciation & Amortization vs competitors

How SMTI compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +456.0% is the highest of 10, against a peer median of +3.1%.
  • Depreciation & amortization amounts to 26.1% of revenue for SMTI, versus a peer median of 4.9%.
SMTI Competitors
Depreciation & Amortization for SMTI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NEONeoGenomics, Inc.LTM Jun 2026$65.46M USD-8.0%-0.8%8.5%
TBRGTruBridge, Inc.LTM Mar 2026$43.33M USD+48.8%-17.1%12.5%
VMDViemed Healthcare, Inc.LTM Mar 2026$29.62M USD+15.3%+22.3%10.3%
SMTISanara MedTech Inc.LTM Mar 2026$28.02M USD+456.0%+129.2%26.1%
HITIHigh Tide Inc.LTM Apr 2026CA$20.61M CAD-9.5%-6.9%3.1%
LFMDLifeMD, Inc.LTM Mar 2026$2.76M USD-127.4%-55.7%1.3%
XGNExagen Inc.LTM Mar 2026$2.28M USD+33.5%+10.8%3.3%
STXSStereotaxis, Inc.LTM Mar 2026$1.58M USD+31.8%+53.6%5.1%
SGHTSight Sciences, Inc.LTM Mar 2026$690K USD+3.1%-11.8%0.9%
TRDAEntrada Therapeutics, Inc.LTM Mar 2026$284K USD-92.5%+29.3%4.9%
Peer median (excluding SMTI) —+3.1%-0.8%4.9%

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(7.99M)(8.09M)(4.44M)(9.91M)(27.66M)
Depreciation & Amortization596.98K2.37M3.68M4.92M28.56M
Deferred Income Tax0(5.84M)000
Stock-Based Compensation2.67M2.7M3.44M4.44M718.71K
Change in Working Capital(1.18M)517.62K(3.28M)(911.72K)(3.84M)
Accounts Receivables(774.81K)(2.27M)(1.73M)(4.54M)4.03M
Inventory(1.15M)(517.27K)(1.55M)1.44M(431.33K)
Accounts Payables99.13K(423.75K)575.15K(471.21K)1.24M
Other Working Capital645.56K3.73M(577.32K)2.66M(8.68M)
Other Non-Cash Items1.1M2.79M(2.64M)1.44M9.02M
Operating Cash Flow(4.81M)(5.55M)(3.25M)(23.78K)6.79M
Capital Expenditures(750.45K)(747.02K)(265.25K)(229.3K)(4.63M)
Acquisitions (Net)0(2.52M)(9.94M)00
Purchases of Investments(4.53M)(250K)0(5.3M)9.48M
Sales of Investments0000(2.96M)
Other Investing Activities(578.59K)(598.45K)650(1.1M)(10.47M)
Investing Cash Flow(5.28M)(3.51M)(10.21M)(6.61M)(8.36M)
Debt Repayment009.69M19.59M0
Common Stock Issued28.94M0911.37K00
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(642.53K)(627.35K)(958.59K)(2.15M)(8.48M)
Financing Cash Flow28.3M(627.35K)9.64M17.37M(8.48M)
Effect of Forex Changes00000
Net Change in Cash18.2M(9.69M)(3.81M)10.73M(10.03M)
Free Cash Flow(5.56M)(6.3M)(3.51M)(253.08K)2.16M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.